| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,712.04 | $1,712.04 | $1,712.04 |
Intravenous Infusion Or Subcutaneous Injection Casirivimab And Imdevimab Includes Infusion Or Injection And Post Administration Monitoring In The Home Or Residence This Includes A Beneficiarys Home That Has Been Made Provider-Based To The Hospital During The Covid-19 Public Health Emergency Subsequent Repeat Doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,712.04 | $1,712.04 | $1,712.04 |